Page last updated: 2024-10-24

cetirizine and Idiopathic Parkinson Disease

cetirizine has been researched along with Idiopathic Parkinson Disease in 1 studies

Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekimova, IV1
Plaksina, DV1
Pastukhov, YF1
Lapshina, KV1
Lazarev, VF1
Mikhaylova, ER1
Polonik, SG1
Pani, B1
Margulis, BA1
Guzhova, IV1
Nudler, E1

Other Studies

1 other study available for cetirizine and Idiopathic Parkinson Disease

ArticleYear
New HSF1 inducer as a therapeutic agent in a rodent model of Parkinson's disease.
    Experimental neurology, 2018, Volume: 306

    Topics: Animals; Antiparkinson Agents; Cetirizine; Gene Knockdown Techniques; Heat Shock Transcription Facto

2018